Education
About Us
Working with TipRanks
Follow Us
Wai Yuen Tong Medicine Holdings Limited (HK:0897)
:0897
RESEARCH TOOLSreports
Total Valuation
Wai Yuen Tong Medicine Holdings Limited has a market cap or net worth of HK$393.79M. The enterprise value is ―.
Market CapHK$393.79M
Enterprise Value―
Share Statistics
Wai Yuen Tong Medicine Holdings Limited has 1,125,102,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,125,102,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Wai Yuen Tong Medicine Holdings Limited’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 1.09%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)1.09%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee959.46K
Profits Per Employee60.82K
Employee Count817
Asset Turnover0.37
Inventory Turnover1.26
Valuation Ratios
The current PE Ratio of Wai Yuen Tong Medicine Holdings Limited is -18.92. Wai Yuen Tong Medicine Holdings Limited’s PEG ratio is 0.60.
PE Ratio-18.92
PS Ratio0.00
PB Ratio0.33
Price to Fair Value0.21
Price to FCF3.87
Price to Operating Cash Flow3.72
PEG Ratio0.60
Income Statement
In the last 12 months, Wai Yuen Tong Medicine Holdings Limited had revenue of 783.88M and earned -15.36M in profits. Earnings per share was -0.01.
Revenue783.88M
Gross Profit394.81M
Operating Income40.88M
Pretax Income-13.63M
Net Income-15.36M
EBITDA138.31M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 106.12M and capital expenditures -4.49M, giving a free cash flow of 101.63M billion.
Operating Cash Flow106.12M
Free Cash Flow101.63M
Free Cash Flow per Share0.09
Dividends & Yields
Wai Yuen Tong Medicine Holdings Limited pays an annual dividend of HK$0.176, resulting in a dividend yield of 8.57%
Dividend Per ShareHK$0.176
Dividend Yield8.57%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change200.00%
50-Day Moving Average0.35
200-Day Moving Average0.28
Relative Strength Index (RSI)54.49
Average Volume (3m)535.97K
Important Dates
Wai Yuen Tong Medicine Holdings Limited upcoming earnings date is Jul 1, 2025, TBA Not Confirmed.
Last Earnings DateNov 27, 2024
Next Earnings DateJul 1, 2025
Ex-Dividend DateAug 22, 2024
Financial Position
Wai Yuen Tong Medicine Holdings Limited as a current ratio of 2.18, with Debt / Equity ratio of 33.40%
Current Ratio2.18
Quick Ratio1.37
Debt to Market Cap1.59
Net Debt to EBITDA2.93
Interest Coverage Ratio1.00
Taxes
In the past 12 months, Wai Yuen Tong Medicine Holdings Limited has paid -6.36M in taxes.
Income Tax-6.36M
Effective Tax Rate0.47
Enterprise Valuation
Wai Yuen Tong Medicine Holdings Limited EV to EBITDA ratio is 5.03, with an EV/FCF ratio of 4.43.
EV to Sales0.89
EV to EBITDA5.03
EV to Free Cash Flow4.43
EV to Operating Cash Flow3.63
Balance Sheet
Wai Yuen Tong Medicine Holdings Limited has HK$108.90M in cash and marketable securities with HK$400.77M in debt, giving a net cash position of HK$291.87M billion.
Cash & Marketable SecuritiesHK$108.90M
Total DebtHK$400.77M
Net CashHK$291.87M
Net Cash Per ShareHK$0.26
Tangible Book Value Per ShareHK$1.17
Margins
Gross margin is 52.11%, with operating margin of 5.22%, and net profit margin of -1.96%.
Gross Margin52.11%
Operating Margin5.22%
Pretax Margin-1.74%
Net Profit Margin-1.96%
EBITDA Margin17.64%
EBIT Margin3.46%
Analyst Forecast
The average price target for Wai Yuen Tong Medicine Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-66.75%
EPS Growth Forecast-83.83%